Derefter tager den behandlende læge en individuel beslutning om langtidsbehandling.
It is recommended that patients should be evaluated at least every second year in the 4-year period after initiation of treatment with Rebif and a decision for longer term treatment should then be made on an individual basis by the treating physician.